PharmaVentures

PharmaVentures InSights provides featured interviews and insight with industry leaders from the pharma, biotech and financial sectors.

[PharmaVentures @PharmaTV]

PharmaVentures is sorry to announce the passing of our Non-Executive Board Member Charles Macfarlane. He passed away last Saturday 15th June.

Charles was an exceptional man and truly unique. The combination of high intellect and wonderful charm made him…https://t.co/qQYYrlk9Am

[PharmaVentures @PharmaTV]

It’s been a privilege to have served as Board Member of this exciting NZ company. Within 9 months of joining the Board the company has been acquired by an Insight Ventures investment company Graphpad in the US. https://t.co/W1iJfDmkEK

[PharmaVentures @PharmaTV]

It has been a privilege to serve as a non-executive board member of this exciting NZ company. Within just 9 months of joining Biomatters the company was acquired. Innovation and entrepreneurialism is alive and kicking in New Zealand. https://t.co/IRyv04wxW4

[PharmaVentures @PharmaTV]

Absolutely Eric!! We extend our congratulations to Sir Greg Winter. https://t.co/uHKtxnOmPL

[PharmaVentures @PharmaTV]

Why should you make South Korea a deal making target? You are invited to watch our exclusive video discussion. LIVE today at 3pm BST and 6pm BST
For more details register here: https://t.co/OKvdE7a9ET @PharmaVentures

[PharmaVentures @PharmaTV]

https://t.co/50wZCheQs8

[PharmaVentures @PharmaTV]

Why you should make South Korea a deal making target? You are invited to watch our exclusive video discussion. August 1st 2018
For more details register here: https://t.co/OKvdE7a9ET @PharmaVentures

[PharmaVentures @PharmaTV]

Why should you make South Korea a deal making target? You are invited to watch our exclusive video discussion. August 1st 2018
For more details register here: https://t.co/OKvdE7a9ET @PharmaVentures

[PharmaVentures @PharmaTV]

Endomag: A better standard of cancer care
https://t.co/EvjgpXnViU via @YouTube

[PharmaVentures @PharmaTV]

https://t.co/BjQsNqD8i5

[Zyme Communications @ZymeComms]

Endomag raises $10 million USD (£8M GBP) to establish a new standard of breast cancer care @endomag https://t.co/rDodZtvjPW

[PharmaVentures @PharmaTV]

Knock your next deal out of the park. Meet with @PharmaVentures in Boston at the 2018 BIO International Convention - June 4th - 7th https://t.co/q6Y2N2M6No

[Adrian Dawkes @adawkes]

Another great addition for us at PharmaVentures!
PharmaVentures Strengthens its First Class Healthcare Strategy and Dealmaking Capabilities With the https://t.co/aybewo4xD0

[PharmaVentures, The Deal Experts @PharmaVentures]

PharmaVentures Strengthens Its First Class Strategy Consulting & Dealmaking Capabilities - https://t.co/MQF362mQEN

[PharmaVentures @PharmaTV]

Watch the final interview here https://t.co/3TOBMkgPR3 https://t.co/R9SMdSwcOV

[IB Communications Ltd @IBcommsagency]

Great to arrange the interview for Stephane Boissel, @TxCellSA with @PharmaTV at @BiotechandMoney covering #celltherapy CAR-Tregs

[PharmaVentures @PharmaTV]

Find out how the Sino-UK Fund is the bridge between the UK and China. @PharmaVentures @simonnhaworth Watch the FULL INTERVIEW here https://t.co/kttHqNVzYF

[PharmaVentures @PharmaTV]

PREVIEW Interview with NetScientific: Fighting chronic diseases on three fronts @PharmaVentures FULL interview here - https://t.co/I9v1iLrpT6

[PharmaVentures @PharmaTV]

PREVIEW interview with BioSeed Capital: Aiming for new drugs, new deliveries and new cures @PharmaVentures FULL interview here - https://t.co/YJagUEWODq

[PharmaVentures, The Deal Experts @PharmaVentures]

Are you Divesting or Acquiring at DCAT? - https://t.co/5Hvf2kGBS6

[PharmaVentures @PharmaTV]

Watch:JJDC: Supporting the global entrepreneurial community https://t.co/BRsmqtHf92 #PharmaTV Pharmaventures

[PharmaVentures @PharmaTV]

Watch:NNRCO: Strategic alliance between Oxford University and Novo Nordisk https://t.co/i67oPHxg0s #PharmaTV Pharmaventures